NF-κB and RANKL are involved in BC tumorigenesis, chemotherapy resistance, and survival rate [13], as well as in the dysregulation of the bone remodeling process by stimulating osteoclastogenesis and impeding osteogenesis [14,15,16]. This evidence concerns the gene NFKB1 and breast cancer.